UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018031
Receipt number R000020889
Scientific Title Systemic inflammation and motor prognosis in Parkinson disease: a retrospective study
Date of disclosure of the study information 2015/06/22
Last modified on 2015/06/29 15:35:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Systemic inflammation and motor prognosis in Parkinson disease: a retrospective study

Acronym

Inflammation-PD study

Scientific Title

Systemic inflammation and motor prognosis in Parkinson disease: a retrospective study

Scientific Title:Acronym

Inflammation-PD study

Region

Japan


Condition

Condition

Parkinson disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the longitudinal effect of the baseline CRP concentrations on motor prognosis of Parkinson disease (PD).

Basic objectives2

Others

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome measure was the change of the Unified PD Rating Scale Part III scores (on period) from the study enrollment to each of the five follow-up periods (the Day 1-90, 91-270, 271-450, 451-630, and 631-900).

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with PD who fulfilled the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria (steps 1 and 2), who were admitted to the Department of Neurology of National Regional Center for Neurological Disorders and National Hospital of Utano between January 2008 and December 2013. Subjects with both of the following conditions were included. (i) Plasma concentrations of high-sensitivity CRP for screening blood test were measured in the period when patients were not diagnosed as having any infections. (ii) Modified Hoehn and Yahr stage 4 or less at baseline.

Key exclusion criteria

Subjects with any of the following conditions were excluded. (i) Patients who developed dementia within 1 year of the onset of parkinsonism based on consideration of dementia with Lewy bodies (1-year rule).23 (ii) History of brain surgery. (iii) Having any infections within the one month prior to the enrollment. (iv) Concomitant chronic inflammatory diseases including autoimmune diseases or malignancy. (v) Taking corticosteroids.

Target sample size

192


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideyuki Sawada

Organization

Utano National Hospital

Division name

Clinical Research Center

Zip code


Address

8 Ondoyamacho, Narutaki, Ukyoku, Kyoto

TEL

81-75-461-5121

Email

sawada@unh.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideyuki Sawada

Organization

Utano National Hospital

Division name

Clinical Research Center

Zip code


Address

8 Ondoyamacho, Narutaki, Ukyoku, Kyoto

TEL

81-75-461-5121

Homepage URL


Email

sawada@unh.hosp.go.jp


Sponsor or person

Institute

Utano National Hospital

Institute

Department

Personal name



Funding Source

Organization

Clinical Research Center, Utano National Hospital

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 19 Day

Date of IRB


Anticipated trial start date

2014 Year 09 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Under review.


Management information

Registered date

2015 Year 06 Month 22 Day

Last modified on

2015 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020889


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2015/06/29 PD_crp data set.xlsx